Framer vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
No-code website builder reaching $50M ARR in August 2025 at $2B valuation with 500K MAU; used by 40% of YC's latest batch and Perplexity competing with Webflow for design-quality sites.
About
Framer is a professional no-code website builder and design tool used by marketing teams, startups, and design-led companies to create responsive, interactive websites without writing code — combining the visual fidelity of a design tool (Figma-like precision) with the publishing infrastructure of a CMS, enabling teams to go from design to live website without a separate development handoff. Founded in Amsterdam and backed by $161 million total funding including a $100 million Series D in August 2025 at a $2 billion valuation, Framer reached $50 million ARR in August 2025 (doubling from $25 million in 2024) with 500,000 monthly active users including Miro, Perplexity, Scale AI, and 40% of Y Combinator's latest batch.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.